A Comparative Analysis of International Drug Price Negotiation Frameworks: An Interview Study of Key Stakeholders.
Iselin Dahlen SyversenKevin SchulmanAaron S KesselheimWilliam B FeldmanPublished in: The Milbank quarterly (2024)
High-income countries around the world adopt different approaches to conducting price negotiations on brand-name drugs but coalesce around a set of practices that will largely be absent from the current Medicare negotiation framework. US policymakers might consider adding some of these characteristics in the future to improve negotiation outcomes.